Cited by 52Cytokine Signaling Pathways and InteractionsMass Spectrometry Techniques and ApplicationsAdvanced Proteomics Techniques and Applications

Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry

Heidelberger, Sibylle, Zinzalla, Giovanna, Antonow, Dyeison, Essex, Samantha, Piku Basu, B., Palmer, Jonathan, Husby, Jarmila, Jackson, Paul J.M. +4 more·2013·Bioorganic & Medicinal Chemistry Letters

Abstract

STAT3 (Signal Transducer and Activator of Transcription factor 3) is constitutively active in a wide range of human tumours. Stattic is one of the first non-peptidic small molecules reported to inhibit formation of the STAT3:STAT3 protein dimer complex. A mass spectrometry method has been developed to investigate the binding of Stattic to the un-phosphorylated STAT3βtc (U-STAT3) protein. Alkylation of four cysteine residues has been observed with possible reaction at a fifth which could account for the mechanism of action.

Integrity signals

Registry

Crossref · 10.1016/j.bmcl.2013.05.066

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heidelberger, S., Zinzalla, G., Antonow, D., Essex, S., Piku Basu, B., Palmer, J., Husby, J., Jackson, P. J. M., Rahman, K. M., Wilderspin, A. F., Zloh, M., & Thurston, D. E.
Affiliations
  • UCL School of Pharmacy (GB)
  • Karolinska Institutet (SE)
  • King's College London (GB)
Corresponding author
Thurston, David E.
Venue
Bioorganic & Medicinal Chemistry Letters
Publisher
Elsevier BV
Published
2013-08
Volume
23
Issue
16
Pages
4719-4722
ISSN
0960-894X (ISSN-L)
OpenAlex
W2083532042
Cited by
52
References
3
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 6 · 2020: 11 · 2019: 7 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 2
FWCI
2.14
Type
journal article
Language
en
Open access
closed
Locations
  • Bioorganic & Medicinal Chemistry Letters (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
Funders
Cancer Research UK (C180/A9327)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
STAT3, Stattic, protein alkylation, cysteine residues, small molecule inhibitors, binding mechanism
MeSH terms
Alkylating Agents, Amino Acid Sequence, Binding Sites, Cyclic S-Oxides, Humans, Models, Molecular, Proteins, Mass Spectrometry, Molecular Structure, Dimerization, STAT3 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review